Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07361432 · ClinicalTrials.gov registry record · Phase 3
Digital Treatment for Chronic Pain and Addiction in Veterans With Opioid Use Disorder Receiving Buprenorphine
A Phase 3 study, sponsored by VA Office of Research and Development.
- Not yet
- Registry status
- Phase 3
- Development phase
- 250
- Enrollment target
NCT07361432: Clinical Trial Phase 3 study, sponsored by VA Office of Research and Development.
NCT07361432 is a Phase 3 study that has not yet begun recruiting, run by VA Office of Research and Development. The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07361432, a Phase 3 study, has not yet begun recruiting, sponsored by VA Office of Research and Development.
- NOT YET RECRUITING
- Registry status
- Phase 3
- Development phase
- 250 participants
- Enrollment target
Study Summary
Chronic pain is common in individuals with opioid use disorder (OUD) and the first-line treatment, Medication for OUD (MOUD), does not address the considerable functional impairments associated with chronic pain. Veterans with OUD and chronic pain could benefit from integrated, behavioral treatment for chronic pain and addiction, but VHA MOUD clinics often lack the resources to offer these services. The proposed study will examine the effectiveness of an evidence-based digital chronic pain and addiction treatment that Veterans can do from home, which can provide a flexible option for Veterans to engage in treatment from home and the Veterans Health Administration (VHA) a means to provide care without placing trained clinicians at each facility.
Interventions
- BEHAVIORAL Enhanced Treatment as Usual (ETAU)
- BEHAVIORAL Integrating the Management of Pain and Addiction via Collaborative Treatment (IMPACT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2026-11-02 |
| Est. Completion | 2030-05-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07361432
The ClinicalTrials.gov registry entry for NCT07361432 describes a study currently listed as not yet recruiting, categorized as Phase 3. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Enhanced Treatment as Usual (ETAU) is the first listed.
NCT07361432 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07361432 about?
NCT07361432 is a clinical study titled "Digital Treatment for Chronic Pain and Addiction in Veterans With Opioid Use Disorder Receiving Buprenorphine". Chronic pain is common in individuals with opioid use disorder (OUD) and the first-line treatment, Medication for OUD (MOUD), does not address the considerable functional impairments associated with chronic pain. Veterans with OUD and chronic pain could benefit from integrated, behavioral treatment ...
What is the current status of trial NCT07361432?
This trial is currently not yet recruiting. It is a Phase 3 study. The enrollment target is 250 participants. The study started on 2026-11-02. Estimated completion is 2030-05-31.
What interventions are being tested in trial NCT07361432?
The interventions under investigation include: Enhanced Treatment as Usual (ETAU) (BEHAVIORAL), Integrating the Management of Pain and Addiction via Collaborative Treatment (IMPACT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07361432?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.